VENESSA PAYNE: Open Payments
NPI 1437781283 · EDMOND, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,008 in 18 payments from 12 companies in 2025. Trend: 2023 $21 · 2024 $512 · 2025 $1,008
Food & beverage: $1,008
| Company | Payments | Amount |
|---|---|---|
| Janssen Pharmaceuticals, Inc | 3 | $283 |
| Otsuka America Pharmaceutical, Inc. | 1 | $125 |
| Xeris Pharmaceuticals, Inc. | 1 | $124 |
| SANOFI-AVENTIS U.S. LLC | 1 | $119 |
| ACADIA Pharmaceuticals Inc | 1 | $110 |
| Pharmacosmos Therapeutics Inc. | 3 | $76 |
| Organon LLC | 3 | $73 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $27 |
| Amgen Inc. | 1 | $25 |
| Alkermes, Inc. | 1 | $16 |
Products named: SPRAVATO, REXULTI, GVOKE HYPOPEN, TZIELD, NUPLAZID, MONOFERRIC, NEXPLANON, KRYSTEXXA.
Industry payments across OK — which companies pay providers there.
